Table 3.
GMT grouped by prior infection and NH/Control
| Reaction | SARS-CoV-2-naïve, control | Prior SARS-CoV-2, control | SARS-CoV-2-naïve, NH | Prior SARS-CoV-2, NH | ||||
|---|---|---|---|---|---|---|---|---|
| Yes | No | Yes | No | Yes | No | Yes | No | |
| Number of Subjects | 69 | 6 | 29 | 4 | 15 | 36 | 12 | 22 |
| Anti-Spike GMT(95% CI) |
4533 (3485, 5895) |
1798 (175, 18493) |
10956 (7220, 16625) |
6618 (601, 72937) |
2683 (1858, 3874) | 776 (321, 1872) | 14977 (5867, 38234) | 7896 (4201, 14842) |
| Anti-RBD GMT(95% CI) | 4293 (3128, 5891) | 1455 (124, 17115) | 11375 (6920, 18700) | 6891 (415, 114477) | 1993 (1188, 3344) | 628 (270, 1464) | 15887 (5608, 45006) | 6578 (3036, 14252) |
| Neutralizing titer GMT (95% CI) |
538 (415, 698) |
108 (25, 471) |
1642 (823, 3277) |
1320 (40, 44061) |
156 (91, 267) |
111 (61, 204) |
1336 (352, 5064) | 641 (276, 1489) |
NH nursing home, RBD receptor-binding domain, GMT geometric mean titre, CI confidence interval